Approval and Legislation Involved in Development of Medical Devices in Dentistry – A Systematic Review
Approval and Legislation of Medical Devices in Dentistry
DOI:
https://doi.org/10.54393/pbmj.v5i6.495Keywords:
Legislation, Medical Devices, Dentistry, Development of DevicesAbstract
A medical device is defined as “any an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent” and “intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals”. Objective: The objective of this systematic review was to outline the steps and necessary requirements needed for approval and legislation of new medical devices. Methods: Two databases; PubMed and Google Scholar were electronically searched for articles published from year 2011 to 2021. The following MeSH (Medical Subjects Headings) terms; “new medical devices”, “Regulatory Bodies”, “Approval Medical Devices”, “Pre-market Post-market Approval” along with Boolean operators AND, OR and NOT were used to search for the articles. Results: It is evident from our study that risks associated with new medical and dental devices are being taken seriously by the governments of different countries and intensive work is done to minimize the risks and maximize the benefits of them. Conclusions: It is safe to say that we are entering a new era of safe medical practice along with new and better devices being available for the public. The reforms being made will help not only the hospitals and patients but will also assist the manufacturers in understanding the mechanisms involved in clearing their products for the approval. It will lead to advancement and reshaping healthcare system to combat many challenges faced by it and promote and protect the public health.
References
Marjenin T, Scott P, Bajaj A, Bansal T, Berne B, Bowsher K et al. FDA Perspectives on the Regulation of Neuromodulation Devices. Neuromodulation. 2020 Jan;23(1):3-9. doi: 10.1111/ner.13085.
Niimi S. [Practice of Regulatory Science (Development of Medical Devices)]. Yakugaku Zasshi. 2017 Jan;137(4):431-437. Japanese. doi: 10.1248/yakushi.16-00244-3.
Mack MJ, Adams DH. Regulatory approval and practice guidelines involving cardiovascular valve devices: determining the right evidentiary bar. Journal of the American College of Cardiology. 2020 Aug 25;76(8):992-5.
Jiang N, Mück JE, Yetisen AK. The Regulation of Wearable Medical Devices. Trends Biotechnol. 2020 Feb;38(2):129-133. doi: 10.1016/j.tibtech.2019.06.004.
Van Norman GA. Drugs, Devices, and the FDA: Part 1: An Overview of Approval Processes for Drugs. JACC Basic Transl Sci. 2016 Apr 25;1(3):170-179. doi: 10.1016/j.jacbts.2016.03.002.
Mori K, Watanabe M, Horiuchi N, Tamura A, Kutsumi H. The role of the Pharmaceuticals and Medical Devices Agency and healthcare professionals in post-marketing safety. Clinical Journal of Gastroenterology. 2014 Apr;7(2):103-7. doi.org/10.1007/s12328-014-0474-6.
Mann EA, Nandkumar S, Addy N, Demko BG, Freedman NS, Gillespie MB et al. Study design considerations for sleep-disordered breathing devices. J Clin Sleep Med. 2020 Mar 15;16(3):441-449. doi: 10.5664/jcsm.8226.
Lee SY, Kim JR, Kim ER, Lee JH, Lee CH, Park CW. A study on development of guideline on writing technical document for electrical medical devices: Bone absorptiometric X-ray System. Journal of radiological science and technology. 2016 Jun; 39(2):263-71. doi.org/10.17946/JRST.2016.39.2.16.
Sorenson C, Drummond M. Improving medical device regulation: the United States and Europe in perspective. Milbank Q. 2014 Mar;92(1):114-50. doi: 10.1111/1468-0009.12043.
Jones AD III, Mi G, Webster TJ. A Status Report on FDA Approval of Medical Devices Containing Nanostructured Materials. Trends Biotechnol. 2019 Feb;37(2):117-120. doi: 10.1016/j.tibtech.2018.06.003.
Jarow JP, Baxley JH. Medical devices: US medical device regulation. Urol Oncol. 2015 Mar;33(3):128-32. doi: 10.1016/j.urolonc.2014.10.004.
Rome BN, Kramer DB, Kesselheim AS. Approval of high-risk medical devices in the US: implications for clinical cardiology. Curr Cardiol Rep. 2014 Jun;16(6):489. doi: 10.1007/s11886-014-0489-0.
Jazowski SA, Winn AN. The Role of the FDA and Regulatory Approval of New Devices for Diabetes Care. Curr Diab Rep. 2017 Jun;17(6):40. doi: 10.1007/s11892-017-0871-6.
Marcus HJ, Payne CJ, Hughes-Hallett A, Marcus AP, Yang GZ, Darzi A et al. Regulatory approval of new medical devices: cross sectional study. BMJ. 2016 May 20;353:i2587. doi: 10.1136/bmj.i2587.
Rathi VK, Krumholz HM, Masoudi FA, Ross JS. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011. JAMA. 2015 Aug 11;314(6):604-12. doi: 10.1001/jama.2015.8761.
Fargen KM, Frei D, Fiorella D, McDougall CG, Myers PM et al. The FDA approval process for medical devices: an inherently flawed system or a valuable pathway for innovation? J Neurointerv Surg. 2013 Jul;5(4):269-75. doi: 10.1136/neurintsurg-2012-010400.
Hihara H, Tagaino R, Washio J, Laosuwan K, Wicaksono DP, Izumita K et al. Effectiveness and safety of a new dental plaque removal device utilizing micro mist spray for removing oral biofilm in vitro. BMC Oral Health. 2021 Dec;21(1):1-8. doi.org/10.1186/s12903-021-01647-4.
Zuckerman D, Brown P, Das A. Lack of publicly available scientific evidence on the safety and effectiveness of implanted medical devices. JAMA Intern Med. 2014 Nov;174(11):1781-7. doi: 10.1001/jamainternmed.2014.4193.
Faris O, Shuren J. An FDA viewpoint on unique considerations for medical-device clinical trials. New England Journal of Medicine. 2017 Apr 6;376(14):1350-7. DOI: 10.1056/NEJMra1512592.
Johnston JL, Dhruva SS, Ross JS, Rathi VK. Early experience with the FDA's Breakthrough Devices program. Nat Biotechnol. 2020 Aug;38(8):933-938. doi: 10.1038/s41587-020-0636-7.
Jokura Y, Yano K, Yamato M. Comparison of the new Japanese legislation for expedited approval of regenerative medicine products with the existing systems in the USA and European Union. J Tissue Eng Regen Med. 2018 Feb;12(2):e1056-e1062. doi: 10.1002/term.2428.
Rathi VK, Krumholz HM, Masoudi FA, Ross JS. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011. JAMA. 2015 Aug 11;314(6):604-12. doi: 10.1001/jama.2015.8761.
Zuckerman DM, Brown P, Nissen SE. Medical device recalls and the FDA approval process. Arch Intern Med. 2011 Jun 13;171(11):1006-11. doi: 10.1001/archinternmed.2011.30.
Fink M, Akra B. Regulatory clearance: How are outcome measurements critical? Injury. 2020 May;51 Suppl 2:S67-S70. doi: 10.1016/j.injury.2019.10.071.
Pane J, Francisca RDC, Verhamme KMC, Orozco M, Viroux H, Rebollo I et al. EU postmarket surveillance plans for medical devices. Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1155-1165. doi: 10.1002/pds.4859.
Wilkinson J, Crosbie A. A UK medical devices regulator's perspective on registries. Biomed Tech (Berl). 2016 Apr 1;61(2):233-7. doi: 10.1515/bmt-2015-0142.
Howard JJ. Balancing innovation and medical device regulation: the case of modern metal-on-metal hip replacements. Med Devices (Auckl). 2016 Aug 9;9:267-75. doi: 10.2147/MDER.S113067.
Beckers R, Kwade Z, Zanca F. The EU medical device regulation: Implications for artificial intelligence-based medical device software in medical physics. Phys Med. 2021 Mar;83:1-8. doi: 10.1016/j.ejmp.2021.02.011.
Cipriani A, Ioannidis JPA, Rothwell PM, Glasziou P, Li T, Hernandez AF et al. Generating comparative evidence on new drugs and devices after approval. Lancet. 2020 Mar 21;395(10228):998-1010. doi: 10.1016/S0140-6736(19)33177-0.
Wong KA, Hodgson L, Garas G, Malietzis G, Markar S, Rao C et al. How can cardiothoracic and vascular medical devices stay in the market? Interact Cardiovasc Thorac Surg. 2016 Dec;23(6):940-948. doi: 10.1093/icvts/ivw257.
Tahir H, Tahir R, McDonald-Maier K. On the security of consumer wearable devices in the Internet of Things. PLoS One. 2018 Apr 18;13(4):e0195487. doi: 10.1371/journal.pone.0195487.
Kramer DB, Baker M, Ransford B, Molina-Markham A, Stewart Q, Fu K et al. Security and privacy qualities of medical devices: an analysis of FDA postmarket surveillance. PLoS One. 2012 Jul;7(7):e40200. doi: 10.1371/journal.pone.0040200.
Galasso A, Luo H. Tort reform and innovation. The journal of law and economics. 2017 Aug 1;60(3):385-412. doi.org/10.1086/694337.
Greer SL, Hervey TK, Mackenbach JP, McKee M. Health law and policy in the European Union. The Lancet. 2013 Mar 30;381(9872):1135-44. doi.org/10.1016/S0140-6736(12)62083-2.
Green JIJ. Medical Device Regulation: Requirements for Dental Professionals Who Prescribe and Manufacture Custom-Made Devices. Prim Dent J. 2021 Mar;10(1):64-88. doi: 10.1177/2050168420980980.
Ikeno F, Ikeda K, Uchida T. Patient access to medical devices-what about Japan, the second largest medical device market? Cardiovasc Interv Ther. 2014 Jan;29(1):1-3. doi: 10.1007/s12928-013-0202-z.
Chughtai AA, Khan W. Use of personal protective equipment to protect against respiratory infections in Pakistan: A systematic review. J Infect Public Health. 2019 Jul-Aug;12(4):522-527. doi: 10.1016/j.jiph.2019.01.064.
Food and Drug Administration, HHS. Dental devices; reclassification of blade-form endosseous dental implant. Final order. Fed Regist. 2014 Jun 18;79(117):34623-5.
Dental Devices. Reclassification of Electrical Salivary Stimulator System. Final order. Federal register. 2015 Nov;80(224):72585-6.
Food and Drug Administration, HHS. Medical Devices; Exemption From Premarket Notification; Class II Devices; Over-the-Counter Denture Repair Kit. Final order. Fed Regist. 2018 Mar 14;83(50):11144-5.
Stanley A. A new era for the dental industry. BDJ In Practice. 2020 Apr;33(4):18-9. doi.org/10.1038/s41404-020-0362-3.
Martelli N, Eskenazy D, Déan C, Pineau J, Prognon P, Chatellier G et al. New European Regulation for Medical Devices: What Is Changing? Cardiovasc Intervent Radiol. 2019 Sep;42(9):1272-1278. doi: 10.1007/s00270-019-02247-0.
Gibbs S, Kosten I, Veldhuizen R, Spiekstra S, Corsini E, Roggen E et al. Assessment of metal sensitizer potency with the reconstructed human epidermis IL-18 assay. Toxicology. 2018 Jan 15;393:62-72. doi: 10.1016/j.tox.2017.10.014.
Fraser AG, Byrne RA, Kautzner J, Butchart EG, Szymański P, Leggeri I et al. Implementing the new European Regulations on medical devices-clinical responsibilities for evidence-based practice: a report from the Regulatory Affairs Committee of the European Society of Cardiology. Eur Heart J. 2020 Jul 14;41(27):2589-2596. doi: 10.1093/eurheartj/ehaa382.
Liu W, Shi X, Lu Z, Wang L, Zhang K, Zhang X. Review and approval of medical devices in China: Changes and reform. J Biomed Mater Res B Appl Biomater. 2018 Aug;106(6):2093-2100. doi: 10.1002/jbm.b.34031.
Konishi A, Isobe S, Sato D. New Regulatory Framework for Medical Devices in Japan: Current Regulatory Considerations Regarding Clinical Studies. J Vasc Interv Radiol. 2018 May;29(5):657-660. doi: 10.1016/j.jvir.2017.12.022.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pakistan BioMedical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments editor@pakistanbmj.com